Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

Breast Cancer Res Treat 2011 Nov 5;130(2):449-55. Epub 2011 Feb 5.

Division of Medical Oncology, Sapienza University of Rome, Rome, Italy.

Currently used methods to detect and enumerate circulating tumor cells (CTCs) rely on the expression of the epithelial cell adhesion molecule (EpCAM) and cytokeratins. This selection may exclude cells that have undergone intrinsic modifications of their phenotype, as epithelial-mesenchymal transition (EMT). Aim of the study was to investigate the expression of EMT and stemness markers in CTCs from breast cancer patients in all stages of disease. 92 female breast cancer patients were enrolled. CTCs were isolated by CELLection Dynabeads coated with the monoclonal antibody toward EpCam. Samples found positive for CTCs presence (CD45-/CK+) were evaluated for the expression of ER alpha, HER2, ALDH1, vimentin, and fibronectin. Samples negative for CTCs presence (CD45-/CK-) were also evaluated for the expression of vimentin and fibronectin, used as markers of EMT. CTCs were found in 66% of patients. The distribution of CTCs presence according to stage and grade of disease was found statistically significant. The expression of ALDH1 on CTCs was found to correlate to stage of disease and to the expression of vimentin and fibronectin. In 34% of patients, we detected cells with negative CK/CD45 expression but positive expression of vimentin and fibronectin. There is an urgent need for optimizing CTCs detection methods through the inclusion of EMT markers. The detection of cells in mesenchymal transition, retaining EMT and stemness features, may contribute to discover additional therapeutic targets useful to eradicate micrometastatic disease in breast cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1373-xDOI Listing
November 2011
33 Reads

Publication Analysis

Top Keywords

vimentin fibronectin
16
breast cancer
16
ctcs presence
12
cancer patients
12
expression vimentin
12
ctcs
9
evaluated expression
8
tumor cells
8
expression
8
circulating tumor
8
stemness features
8
epithelial-mesenchymal transition
8
emt stemness
8
patients
5
emt
5
cells
5
fibronectin markers
4
presence cd45-/ck-
4
cd45-/ck- evaluated
4
negative ctcs
4

Altmetric Statistics

References

(Supplied by CrossRef)

M Cristofanilli et al.
N Engl J Med 2004

B Mostert et al.
Cancer Treat Rev 2009

K Pantel et al.
Nat Rev Cancer 2008

A Amadori et al.
Oncology 2009

DF Hayes et al.
Clin Cancer Res 2006

T Gage et al.
MLO Med Lab Obs 2010

S Maheswaran et al.
Curr Opin Genet Dev 2010

M Iwatsuki et al.
Cancer Sci 2010

A Goldhirsch et al.
Ann Oncol 2007

Similar Publications